CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS

被引:0
|
作者
Tsukasa Uchida
Yoshitaka Tamaki
Takashi Ayaki
Akemi Shodai
Seiji Kaji
Toshifumi Morimura
Yoshinori Banno
Kazuchika Nishitsuji
Naomi Sakashita
Takakuni Maki
Hirofumi Yamashita
Hidefumi Ito
Ryosuke Takahashi
Makoto Urushitani
机构
[1] Kyoto University Graduate School of Medicine,Department of Neurology
[2] Molecular Neuroscience Research Center,Department of Molecular Pathology
[3] Shiga University of Medical Science,Department of Neurology
[4] Seta-Tsukinowa-cho,undefined
[5] Tokushima University,undefined
[6] 2-24 Shinkuracho,undefined
[7] Wakayama Medical University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The molecular machinery responsible for cytosolic accumulation of misfolded TDP-43 in amyotrophic lateral sclerosis (ALS) remains elusive. Here we identified a cullin-2 (CUL2) RING complex as a novel ubiquitin ligase for fragmented forms of TDP-43. The von Hippel Lindau protein (VHL), a substrate binding component of the complex, preferentially recognized misfolded TDP-43 at Glu246 in RNA-recognition motif 2. Recombinant full-length TDP-43 was structurally fragile and readily cleaved, suggesting that misfolded TDP-43 is cleared by VHL/CUL2 in a step-wise manner via fragmentation. Surprisingly, excess VHL stabilized and led to inclusion formation of TDP-43, as well as mutant SOD1, at the juxtanuclear protein quality control center. Moreover, TDP-43 knockdown elevated VHL expression in cultured cells, implying an aberrant interaction between VHL and mislocalized TDP-43 in ALS. Finally, cytoplasmic inclusions especially in oligodendrocytes in ALS spinal cords were immunoreactive to both phosphorylated TDP-43 and VHL. Thus, our results suggest that an imbalance in VHL and CUL2 may underlie oligodendrocyte dysfunction in ALS and highlight CUL2 E3 ligase emerges as a novel therapeutic potential for ALS.
引用
收藏
相关论文
共 50 条
  • [1] CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS
    Uchida, Tsukasa
    Tamaki, Yoshitaka
    Ayaki, Takashi
    Shodai, Akemi
    Kaji, Seiji
    Morimura, Toshifumi
    Banno, Yoshinori
    Nishitsuji, Kazuchika
    Sakashita, Naomi
    Maki, Takakuni
    Yamashita, Hirofumi
    Ito, Hidefumi
    Takahashi, Ryosuke
    Urushitani, Makoto
    SCIENTIFIC REPORTS, 2016, 6
  • [2] Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation
    Ormeno, Fernando
    Hormazabal, Juan
    Moreno, Jose
    Riquelme, Felipe
    Rios, Javiera
    Criollo, Alfredo
    Albornoz, Amelina
    Alfaro, Ivan E.
    Budini, Mauricio
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [3] Preclinical proof of concept of SOL-257, a gene therapy targeting misfolded TDP-43 in ALS
    Hishiya, Akinori
    Cox, Gerald
    MUSCLE & NERVE, 2023, 68 : S69 - S69
  • [4] Functional recovery in new mouse models of ALS/FTLD after clearance of TDP-43 pathology
    Walker, A.
    Spiller, K.
    Ge, G.
    Zheng, A.
    Xu, Y.
    Zhou, M.
    Tripathy, K.
    Kwong, L.
    Trojanowski, J.
    Lee, V.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 208 - 209
  • [5] The characterisation of oligodendrocytes derived from IPSC from als patients harbouring point mutations in the TDP-43 gene
    Barton, S.
    Magnani, D.
    Selvaraj, B.
    Livesey, M.
    Cleary, E.
    Vasistha, N.
    Burr, K.
    Story, D.
    Carter, R.
    Morton, N.
    Hardingham, G.
    Wyllie, D.
    Chandran, S.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 126 - 126
  • [6] ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice
    Horiuchi, Mai
    Watanabe, Seiji
    Komine, Okiru
    Takahashi, Eiki
    Kaneko, Kumi
    Itohara, Shigeyoshi
    Shimada, Mayuko
    Ogi, Tomoo
    Yamanaka, Koji
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
  • [7] Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43
    Walker, Adam K.
    Spiller, Krista J.
    Ge, Guanghui
    Zheng, Allen
    Xu, Yan
    Zhou, Melissa
    Tripathy, Kalyan
    Kwong, Linda K.
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    ACTA NEUROPATHOLOGICA, 2015, 130 (05) : 643 - 660
  • [8] Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43
    Adam K. Walker
    Krista J. Spiller
    Guanghui Ge
    Allen Zheng
    Yan Xu
    Melissa Zhou
    Kalyan Tripathy
    Linda K. Kwong
    John Q. Trojanowski
    Virginia M.-Y. Lee
    Acta Neuropathologica, 2015, 130 : 643 - 660
  • [9] Alteration of POLDIP3 Splicing Associated with Loss of Function of TDP-43 in Tissues Affected with ALS
    Shiga, Atsushi
    Ishihara, Tomohiko
    Miyashita, Akinori
    Kuwabara, Misaki
    Kato, Taisuke
    Watanabe, Norihiro
    Yamahira, Akie
    Kondo, Chigusa
    Yokoseki, Akio
    Takahashi, Masuhiro
    Kuwano, Ryozo
    Kakita, Akiyoshi
    Nishizawa, Masatoyo
    Takahashi, Hitoshi
    Onodera, Osamu
    PLOS ONE, 2012, 7 (08):
  • [10] Enhanced secretion of the amyotrophic lateral sclerosis ALS-associated misfolded TDP-43 mediated by the ER-ubiquitin specific peptidase USP19
    Picard, Flavien
    Nonaka, Takashi
    Belotti, Edwige
    Osseni, Alexis
    Errazuriz-Cerda, Elisabeth
    Jost-Mousseau, Coline
    Bernard, Emilien
    Conjard-Duplany, Agnes
    Bohl, Delphine
    Hasegawa, Masato
    Raoul, Cedric
    Galli, Thierry
    Schaeffer, Laurent
    Leblanc, Pascal
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2025, 82 (01)